IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 541 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  Search
 
  
Resource Links
   Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
   Article in PDF (261 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)

 
In This Article
   References

 Article Access Statistics
    Viewed2298    
    Printed36    
    Emailed0    
    PDF Downloaded110    
    Comments [Add]    

Recommend this journal

 


 
 Table of Contents    
LETTER TO THE EDITOR
Year : 2013  |  Volume : 45  |  Issue : 5  |  Page : 541-542
 

Experimental evaluation of analgesic and anti-inflammatory potential of Oyster mushroom Pleurotus florida


Government Medical College, Nagpur, Maharashtra, India

Date of Web Publication6-Sep-2013

Correspondence Address:
Smita D Sontakke
Government Medical College, Nagpur, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0253-7613.117777

Rights and Permissions



How to cite this article:
Sontakke SD, Hire R, Rayasum S. Experimental evaluation of analgesic and anti-inflammatory potential of Oyster mushroom Pleurotus florida. Indian J Pharmacol 2013;45:541-2

How to cite this URL:
Sontakke SD, Hire R, Rayasum S. Experimental evaluation of analgesic and anti-inflammatory potential of Oyster mushroom Pleurotus florida. Indian J Pharmacol [serial online] 2013 [cited 2019 Jun 24];45:541-2. Available from: http://www.ijp-online.com/text.asp?2013/45/5/541/117777


Sir,

This is with reference to the original article 'Experimental evaluation of analgesic and anti-inflammatory potential of oyster mushroom Pleurotus florida by Ganeshpurkar and Rai. [1]

We have following comments on this article:

  1. In the Eddy's hot plate test and tail flick test, neither the type of control used nor its route of administration is mentioned.
  2. What was the basis of evaluating the sedative activity and effect on locomotor performance? Neither the study title nor the objectives mention these.
  3. "Data were analyzed with ANOVA where control group was compared with test groups". Post-test used is not mentioned. Also, if a standard group was used, why was it not compared to the test groups?
  4. The sentence "No significant result was observed which could justify the sedative potential of mushroom" (page 69, para 2) is not clear.
  5. Evaluation of sedative activity and locomotor performance has not been discussed.
  6. The authors have rightly mentioned that tail flick/tail immersion is specific screening method for centrally acting analgesics. In this method the ideal standard should be an opioid analgesic. Nonsteroidal anti-inflammatory drugs (NSAIDs) have been reported not to be much effective in this method. [2] The authors have used diclofenac sodium as a standard which also shows the maximum effect in this method. Though the effects in the diclofenac group and test groups have not been compared statistically, it seems that the effect in diclofenac group is significantly more than the test group. Further, the authors also claim that the analgesic action of the test drug may be due to a central mechanism. This needs to be explained.
  7. Using diclofenac sodium as a standard drug in animal experiments also appears to be improper due to another reason. Use of this drug in animals was found to be the cause of death of vultures, the most efficient scavengers of nature. [3] Following this the Drug Controller General (India) has banned diclofenac sodium for veterinary use. [4]


 
  References Top

1.Ganeshpurkar A, Rai G. Experimental evaluation of analgesic and anti inflammatory potential of Oyster mushroom Pleurotus florida. Indian J Pharmacol 2013;45:66-70.  Back to cited text no. 1
  Medknow Journal  
2.Schleyerbach R, Weithmann KU, Bartlett RR. Analgesic, anti-inflammatory, and anti-pyretic activity. In: Vogel HG, editor. Drug Discovery and Evaluation: Pharmacological Assays. 3 rd ed. Berlin: Springer; 2008. p. 1014-5.   Back to cited text no. 2
    
3.Medhi B, Sewal RK. Ecopharmacovigilance: An issue urgently to be addressed. Indian J Pharmacol 2012;44;547-9.  Back to cited text no. 3
    
4.Order of Drug Controller General (India) Directorate General of Health Services, New Delhi to All State Drug Controllers. F.No.18-03/2006-DC Dated 11 th May 2006. Available from: http://cat.org.in/files/reports/Order_of_the_Director_Controller_General_%28India%29.pdf [Last accessed 2013 Apr 5].  Back to cited text no. 4
    




 

Top
Print this article  Email this article
 

    

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow